Deep Medicine Acquisition Corp. (DMAQ)
NASDAQ (CM) NASDAQ (CM) Primary Summary
DMAQ Chart
Deep Medicine Acquisition Corp. (DMAQ) FAQ
What does "Delisted" mean?
What was the last recorded dividend?
How long did the company pay dividends?
Were there any stock splits?
What was the last known trading price?
Deep Medicine Acquisition Corp. Profile
| Trading Companies & Distributors Industry | Industrials Sector | Humphrey P. Polanen CEO | NASDAQ (CM) Exchange | 243733102 CUSIP |
| US Country | 2 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Deep Medicine Acquisition Corp. is a company founded in 2020, with its headquarters located in New York, New York. At its core, it is a blank check company, meaning it currently does not conduct significant operations on its own. Instead, its primary purpose lies in facilitating a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other similar business combinations. Deep Medicine Acquisition Corp. is strategically focused on the healthcare industry, seeking to identify and engage with businesses within this sector for potential mergers or acquisitions. It operates as a subsidiary of Bright Vision Sponsor LLC, indicating its integration within a larger corporate structure that supports its mission and growth strategies.
Products and Services
Given that Deep Medicine Acquisition Corp. is a blank check company focusing on mergers and acquisitions within the healthcare sector, it does not offer traditional products or services to the public. Instead, its "offerings" can be broken down as follows:
- Merger and Acquisition Facilitation: The primary service offered by Deep Medicine Acquisition Corp. revolves around identifying and executing mergers, acquisitions, capital stock exchanges, asset acquisitions, and similar business combinations. The focus is particularly on entities within the healthcare industry, aiming to leverage emerging opportunities in this sector to create value for shareholders and for the businesses they engage with.
- Strategic Partnership Opportunities: Through its operations, Deep Medicine Acquisition Corp. extends an opportunity for businesses in the healthcare industry to enter into strategic partnerships. By acting as a platform for these entities to merge with or be acquired, it facilitates growth, expansion, and the realization of synergies between the involved companies. This service implicitly underlines the creation of strategic value beyond mere financial transactions, focusing on long-term industry evolution and innovation.
